Xcout Intel
ScandiBio competitors & alternatives
The 12 closest competitors and alternatives to ScandiBio among biotech companies — ranked by similarity to what ScandiBio actually does, not by market-cap band.
Subscribe to see ScandiBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ScandiBio
ScandiBio Therapeutics is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, founded to develop pharmaceutical drugs targeting mitochondrial dysfunction.
ScandiBio at a glance
ScandiBio is a biotech company headquartered in Sweden. Xcout tracks 9 named people at ScandiBio, including Magnus Nylén (Chief Executive Officer (CEO)).
ScandiBio leadership
- Magnus NylénChief Executive Officer (CEO)
- Dr Marianne HanssonChief Financial Officer (CFO)
- Dr Adil MardinoğluChief Scientific Officer (CSO)
- Dr Özlem AltayChief Medical Officer (CMO)
- Dr Mathias UhlénSenior Professor of Microbiology Co-founder, Chairman of the Board
- Dr Adil MardinoğluProfessor of Systems Biology Co-founder
3 more named people on record for ScandiBio, with roles, board committees and tenure — see the full roster →
Top 12 ScandiBio competitors
Ranked by semantic similarity — how close each company is to ScandiBio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Abliva is a company headquartered in Lund, Sweden, focused on delivering mitochondrial health. It leverages in-house R&D capabilities to create a portfolio of projects with various mechanisms of action.
Biotechnology
Atrogi is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, pioneering the development of novel treatments for metabolic disorders.
Life Sciences
MitoRx Therapeutics is a platform biotechnology company headquartered in Oxford, England, developing novel mitochondrial-targeted therapeutics for life sciences.
Similar biotech company
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Biotechnology
Cellvie AG is a biotechnology company based in Zurich, Switzerland, pioneering Therapeutic Mitochondria Transplantation to target cellular energy metabolism.
Biotechnology
Paean Holdings, Inc. (operating as PAEAN Biotechnology) develops mitochondria-based therapeutics designed to treat rare diseases, inflammatory conditions, cancer, and central nervous system disorders. The company utilizes proprietary platforms including mitochondrial transplantation, modified mitochondria for targeted delivery, and mitochondria-augmented cell therapy to address critical medical needs and overcome cellular metabolic limitations.
Biotechnology
Endurance Biotech, Inc. is a biopharmaceutical company that develops first-in-class oral small molecules designed to restore mitochondrial and lysosomal function for the treatment of neurodegenerative, metabolic, and age-related diseases. Its lead clinical program, T-168, targets Parkinson's disease by addressing interconnected cellular systems, reducing neuroinflammation, and enhancing autophagy.
Biotechnology
Mitotherapeutix, LLC is a biotechnology company that develops small interfering RNA (siRNA) based therapeutics targeting difficult disease pathways. The company focuses on modulating mitochondrial metabolic activity by inhibiting a negative gene regulator to treat a wide array of diseases.
Similar biotech company
Calliditas Therapeutics AB is a commercial-stage biopharma company based in Stockholm, Sweden. It focuses on developing and commercializing pharmaceutical products.
Biotechnology
Forward Pharma A/S is a clinical-stage biotechnology company driven by research and discovery, with headquarters located in Denmark.
Biotechnology
Vandria is a biotechnology research company founded in September 2021 and based at the Biopôle campus in Epalinges, Switzerland. The company specializes in discovering first-in-class small molecules targeting mitochondrial function to treat age-related diseases. It operates with a small team focused on novel metabolic pathways.
Biotechnology
SNIPR Biome is a clinical-stage life sciences company headquartered in Copenhagen, Denmark, pioneering precision medicines and CRISPR-guided technologies for difficult-to-treat conditions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ScandiBio and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ScandiBioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →